share_log

Needham Reiterates Buy on Biogen, Maintains $294 Price Target

Moomoo 24/7 ·  Apr 25 05:33

Needham analyst Ami Fadia reiterates Biogen (NASDAQ:BIIB) with a Buy and maintains $294 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment